| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |